(Q37680727)

21 August 2017

1 reference

title

Leukocyte adhesion deficiency type II: long-term follow-up and review of the literature (English)

1 reference

21 August 2017

Yael Gazit

1

1 reference

21 August 2017

Adi Mory

2

1 reference

21 August 2017

Amos Etzioni

3

1 reference

21 August 2017

Moshe Frydman

4

1 reference

21 August 2017

Oded Scheuerman

5

1 reference

21 August 2017

Ruth Gershoni-Baruch

6

1 reference

21 August 2017

Ben-Zion Garty

7

1 reference

21 August 2017

publication date

23 January 2010

1 reference

Journal of Clinical Immunology

21 August 2017

published in

1 reference

21 August 2017

volume

30

1 reference

21 August 2017

issue

2

1 reference

21 August 2017

page(s)

308-313

1 reference

https://scigraph.springernature.com/pub.10.1007/s10875-009-9354-0

21 August 2017

exact match

0 references

cites work

Correction of leukocyte adhesion deficiency type II with oral fucose

1 reference

12 December 2020

Fucose supplementation in leukocyte adhesion deficiency type II

1 reference

12 December 2020

Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: an updated nomenclature for CDG. First International Workshop on CDGS.

1 reference

12 December 2020

Rambam-Hasharon syndrome of psychomotor retardation, short stature, defective neutrophil motility, and Bombay phenotype

1 reference

12 December 2020

Leukocyte adhesion deficiency type II: long-term follow-up

1 reference

12 December 2020

Leukocyte adhesion deficiency II: therapy and genetic defect

1 reference

12 December 2020

Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency

1 reference

12 December 2020

Leukocyte adhesion deficiency II. Advances and open questions

1 reference

12 December 2020

Discontinuation of fucose therapy in LADII causes rapid loss of selectin ligands and rise of leukocyte counts

1 reference

12 December 2020

Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors

1 reference

12 December 2020

Kindlin-3: a new gene involved in the pathogenesis of LAD-III.

1 reference

12 December 2020

Prenatal diagnosis of Rambam-Hasharon syndrome.

1 reference

12 December 2020

LAD-III, a novel group of leukocyte integrin activation deficiencies.

1 reference

12 December 2020

Leukocyte adhesion deficiency (LAD) type II/carbohydrate deficient glycoprotein (CDG) IIc founder effect and genotype/phenotype correlation

1 reference

12 December 2020

Leukocyte adhesion deficiency II patients with a dual defect of the GDP-fucose transporter

1 reference

12 December 2020

The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter

1 reference

12 December 2020

Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency

1 reference

12 December 2020

Insights into leukocyte adhesion deficiency type 2 from a novel mutation in the GDP-fucose transporter gene.

1 reference

12 December 2020

Impairment of the Golgi GDP-L-fucose transport and unresponsiveness to fucose replacement therapy in LAD II patients

1 reference

12 December 2020

Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism

1 reference

12 December 2020

Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation

1 reference

12 December 2020

10.1007/S10875-009-9354-0

Identifiers

DOI

1 reference

21 August 2017

1 reference